• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

未治疗早产儿视网膜病变的晚期视网膜表现和并发症。

Late-Onset Retinal Findings and Complications in Untreated Retinopathy of Prematurity.

机构信息

Retina and Vitreous of Texas, Houston, Texas; Henry Ford Health System, Detroit, Michigan.

Kellogg Eye Center, University of Michigan School of Medicine, Ann Arbor, Michigan.

出版信息

Ophthalmol Retina. 2020 Jun;4(6):602-612. doi: 10.1016/j.oret.2019.12.015. Epub 2019 Dec 24.

DOI:10.1016/j.oret.2019.12.015
PMID:32059986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7282927/
Abstract

PURPOSE

To investigate late retinal findings and complications of eyes with a history of retinopathy of prematurity (ROP) that did not meet treatment criteria and did not receive treatment during infancy.

DESIGN

Retrospective, nonconsecutive, noncomparative, multicenter case series.

PARTICIPANTS

Three hundred sixty-three eyes of 186 patients.

METHODS

Data were requested from multiple providers on premature patients with a history of ROP and no treatment during infancy who demonstrated late retinal findings or complications and included age, gender, gestational age and weight, zone and stage at infancy, visual acuity, current retina vascularization status, vitreous character, presence of peripheral retinal findings such as lattice retinal tears and detachments (RDs), retinoschisis, and fluorescein findings.

MAIN OUTCOME MEASURES

Rate of RDs and factors conferring a higher risk of RDs.

RESULTS

The average age was 34.5 years (range, 7-76 years), average gestational age was 26.6 weeks (range, 23-34 weeks), and average birth weight was 875 g (range, 425-1590 g). Findings included lattice in 196 eyes (54.0%), atrophic holes in 126 eyes (34.7%), retinal tears in 111 eyes (30.6%), RDs in 140 eyes (38.6 %), tractional retinoschisis in 44 eyes (11.9%), and visible vitreous condensation ridge-like interface in 112 eyes (30.5%). Fluorescein angiography (FA) was performed in 113 eyes, of which 59 eyes (52.2%) showed leakage and 16 eyes (14.2%) showed neovascularization. Incomplete vascularization posterior to zone 3 was common (71.6% of eyes). Retinal detachments were more likely in patients with a gestational age of 29 weeks or less (P < 0.05) and in eyes with furthest vascularization to posterior zone 2 eyes compared with zone 3 eyes (P = 0.009).

CONCLUSIONS

Eyes with ROP not meeting the treatment threshold during infancy showed various late retinal findings and complications, of which RDs were the most concerning. Complications were seen in all age groups, including patients born after the Early Treatment for Retinopathy of Prematurity Study. Contributing factors to RDs included atrophic holes within peripheral avascular retina, visible vitreous condensation ridge-like interface with residual traction, and premature vitreous syneresis. We recommend regular examinations and consideration of ultra-widefield FA examinations. Prospective studies are needed to explore the frequency of complications and benefit of prophylactic treatment and if eyes treated with anti-vascular endothelial growth factor therapy are at risk of similar findings and complications.

摘要

目的

研究未接受治疗的早产儿视网膜病变(ROP)患儿的晚期眼部发现和并发症,这些患儿的 ROP 不符合治疗标准且在婴儿期未接受治疗。

设计

回顾性、非连续、非对照、多中心病例系列研究。

参与者

186 名患者的 363 只眼。

方法

从多名提供者处获取有 ROP 病史且婴儿期未接受治疗的早产儿的数据,这些早产儿的晚期视网膜发现或并发症包括年龄、性别、胎龄和体重、婴儿期的区和期、视力、当前视网膜血管化状态、玻璃体特征、是否存在周边视网膜发现,如格子状视网膜裂孔和脱离(RD)、视网膜劈裂和荧光素血管造影(FA)结果。

主要观察指标

RD 的发生率和导致 RD 风险增加的因素。

结果

平均年龄为 34.5 岁(7-76 岁),平均胎龄为 26.6 周(23-34 周),平均出生体重为 875 g(425-1590 g)。发现包括 196 只眼(54.0%)有格子状、126 只眼(34.7%)有萎缩性孔、111 只眼(30.6%)有视网膜裂孔、140 只眼(38.6%)有 RD、44 只眼(11.9%)有牵引性视网膜劈裂、112 只眼(30.5%)有可见玻璃体浓缩脊样界面。对 113 只眼进行了 FA 检查,其中 59 只眼(52.2%)有渗漏,16 只眼(14.2%)有新生血管形成。后部区 3 未完全血管化较为常见(71.6%的眼)。胎龄为 29 周或更小的患者(P < 0.05)和血管化最远至后部区 2 的眼比血管化至区 3 的眼(P = 0.009)更易发生 RD。

结论

婴儿期未达到治疗阈值的 ROP 患儿出现各种晚期眼部发现和并发症,其中 RD 最令人担忧。所有年龄组均可见并发症,包括在早龄早产儿视网膜病变治疗研究后出生的患者。RD 的相关因素包括周边无血管视网膜的萎缩孔、可见玻璃体浓缩脊样界面伴残余牵引和早期玻璃体后脱离。我们建议定期检查,并考虑进行超广角 FA 检查。需要前瞻性研究来探讨并发症的频率和预防性治疗的益处,以及是否接受抗血管内皮生长因子治疗的眼有发生类似发现和并发症的风险。

相似文献

1
Late-Onset Retinal Findings and Complications in Untreated Retinopathy of Prematurity.未治疗早产儿视网膜病变的晚期视网膜表现和并发症。
Ophthalmol Retina. 2020 Jun;4(6):602-612. doi: 10.1016/j.oret.2019.12.015. Epub 2019 Dec 24.
2
Late Vitreoretinal Complications of Regressed Retinopathy of Prematurity: Retinal Break, Vitreous Hemorrhage, and Retinal Detachment.早产儿视网膜病变消退后的晚期玻璃体视网膜并发症:视网膜裂孔、玻璃体积血和视网膜脱离。
Ophthalmol Retina. 2023 Jan;7(1):72-80. doi: 10.1016/j.oret.2022.07.005. Epub 2022 Jul 16.
3
Adult retinopathy of prematurity: outcomes of rhegmatogenous retinal detachments and retinal tears.成人早产儿视网膜病变:孔源性视网膜脱离和视网膜裂孔的治疗结果
Ophthalmology. 2001 Sep;108(9):1647-53. doi: 10.1016/s0161-6420(01)00660-1.
4
Aggressive Posterior Retinopathy of Prematurity Treated with Intravitreal Bevacizumab: Late Period Fluorescein Angiographic Findings.玻璃体腔注射贝伐单抗治疗侵袭性早产儿视网膜病变:晚期荧光素血管造影结果
Graefes Arch Clin Exp Ophthalmol. 2019 Jun;257(6):1141-1146. doi: 10.1007/s00417-019-04292-4. Epub 2019 Mar 20.
5
The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.早产儿视网膜病变的结局:使用结局预测程序筛查早产儿视网膜病变
Ophthalmology. 2001 Jan;108(1):27-34; discussion 34-5. doi: 10.1016/s0161-6420(00)00436-x.
6
Reactivation of Retinopathy of Prematurity in Adults and Adolescents.成人和青少年早产儿视网膜病变的再激活。
Ophthalmol Retina. 2020 Jul;4(7):720-727. doi: 10.1016/j.oret.2020.02.001. Epub 2020 Feb 11.
7
Adult retinopathy of prematurity: retinal complications from cataract surgery.成人早产儿视网膜病变:白内障手术引起的视网膜并发症。
Am J Ophthalmol. 2008 Apr;145(4):729-735. doi: 10.1016/j.ajo.2007.11.007. Epub 2008 Jan 28.
8
Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial.早产儿视网膜病变治疗的修订指征:早产儿视网膜病变早期治疗随机试验结果
Arch Ophthalmol. 2003 Dec;121(12):1684-94. doi: 10.1001/archopht.121.12.1684.
9
Laser photocoagulation (810 nm diode) for threshold retinopathy of prematurity: a prospective randomized pilot study of treatment to ridge and avascular retina versus avascular retina alone.810纳米二极管激光光凝治疗阈值早产儿视网膜病变:一项关于治疗至视网膜嵴和无血管视网膜与仅治疗无血管视网膜的前瞻性随机试点研究。
Int Ophthalmol. 2011 Feb;31(1):3-8. doi: 10.1007/s10792-010-9411-y. Epub 2010 Dec 31.
10
Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15 years.2至15岁儿童早产儿视网膜病变消退后的视网膜脱离
Retina. 2004 Jun;24(3):368-75. doi: 10.1097/00006982-200406000-00006.

引用本文的文献

1
Persistent avascular retina in retinopathy of prematurity.早产儿视网膜病变中的持续性无血管视网膜
Graefes Arch Clin Exp Ophthalmol. 2025 Apr 3. doi: 10.1007/s00417-025-06820-x.
2
A comparation of three different anti-VEGF drugs in development of persistent avascular retina in premature children.三种不同抗血管内皮生长因子(VEGF)药物在早产儿持续性无血管视网膜病变发展中的比较。
Sci Rep. 2024 Dec 28;14(1):31097. doi: 10.1038/s41598-024-82445-0.
3
Ultra-Widefield Optical Coherence Tomography Beyond the Ora Serrata in Retinopathy of Prematurity.

本文引用的文献

1
Extreme Prematurity and Fibroblastic Overgrowth of Persistent Vascular Sheath Behind Each Crystalline Lens: I. Preliminary report.极端早产与每个晶状体后持续性血管鞘的成纤维细胞过度生长:I. 初步报告。
Am J Ophthalmol. 2018 Aug;192:xxviii. doi: 10.1016/j.ajo.2018.05.024.
2
Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists.早产儿视网膜病变:儿科眼科医生的首选诊疗模式
Clin Ophthalmol. 2018 May 25;12:1003-1009. doi: 10.2147/OPTH.S161504. eCollection 2018.
3
Peripheral Vascular Abnormalities Seen by Ultra-Widefield Fluorescein Angiography in Adults With History of Prematurity: Report of Three Cases.
早产儿视网膜病变中超越锯齿缘的超广角光学相干断层扫描
JAMA Ophthalmol. 2025 Feb 1;143(2):165-170. doi: 10.1001/jamaophthalmol.2024.5533.
4
Investigation of the rates of retinopathy of prematurity and other diseases in infants born late preterm: is routine ROP examination required?晚期早产儿视网膜病变及其他疾病发病率的调查:是否需要常规进行早产儿视网膜病变检查?
Eye (Lond). 2025 Apr;39(5):913-917. doi: 10.1038/s41433-024-03506-2. Epub 2024 Nov 28.
5
Innovative Use of Nanomaterials in Treating Retinopathy of Prematurity.纳米材料在治疗早产儿视网膜病变中的创新应用。
Pharmaceuticals (Basel). 2024 Oct 16;17(10):1377. doi: 10.3390/ph17101377.
6
Persistent neovascularization in regressed retinopathy of prematurity.早产儿视网膜病变消退后持续存在的新生血管形成。
Eye (Lond). 2025 Feb;39(Suppl 1):108-109. doi: 10.1038/s41433-024-03392-8. Epub 2024 Oct 14.
7
Surgical Outcomes of Rhegmatogenous Retinal Detachment Associated with Regressed Retinopathy of Prematurity.与早产儿视网膜病变退行性变相关的孔源性视网膜脱离的手术结果。
Turk J Ophthalmol. 2024 Aug 28;54(4):223-227. doi: 10.4274/tjo.galenos.2024.93464.
8
Macular Curvature in Adults Born Preterm With and Without ROP: Results from the Gutenberg Prematurity Eye Study.早产儿中有无 ROP 患者的黄斑曲率:古腾堡早产儿眼病研究的结果。
Invest Ophthalmol Vis Sci. 2024 Mar 5;65(3):39. doi: 10.1167/iovs.65.3.39.
9
Pediatric retinal vascular disorders: From translational sciences to clinical practice.小儿视网膜血管疾病:从转化科学到临床实践
Saudi J Ophthalmol. 2023 Oct 12;37(4):269-275. doi: 10.4103/sjopt.sjopt_63_23. eCollection 2023 Oct-Dec.
10
Evaluation of retinal vascularization in retinopathy of prematurity regressed after intravitreal ranibizumab monotherapy or without treatment based on fluorescein angiography.基于荧光素眼底血管造影评估玻璃体内雷珠单抗单药或无治疗治疗后消退的早产儿视网膜病变的视网膜血管化。
Sci Rep. 2023 Nov 15;13(1):19946. doi: 10.1038/s41598-023-47212-7.
超宽视野荧光素血管造影术在有早产史成人中观察到的外周血管异常:三例报告
Ophthalmic Surg Lasers Imaging Retina. 2018 Apr 1;49(4):278-283. doi: 10.3928/23258160-20180329-13.
4
FLUORESCEIN ANGIOGRAPHIC EVALUATION OF PERIPHERAL RETINAL VASCULATURE AFTER PRIMARY INTRAVITREAL RANIBIZUMAB FOR RETINOPATHY OF PREMATURITY.早产儿视网膜病变初次玻璃体内雷珠单抗治疗后周边视网膜血管的荧光素血管造影评估。
Retina. 2019 Apr;39(4):700-705. doi: 10.1097/IAE.0000000000001996.
5
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings.1 型早产儿视网膜病变玻璃体腔内注射贝伐单抗与激光治疗的 4 年随访:荧光血管造影结果。
Ophthalmology. 2018 Feb;125(2):218-226. doi: 10.1016/j.ophtha.2017.08.005. Epub 2017 Sep 1.
6
PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY.早产儿视网膜病变应用贝伐单抗后预防性周边激光和荧光血管造影。
Retina. 2018 Apr;38(4):764-772. doi: 10.1097/IAE.0000000000001581.
7
Ocular Morbidity Associated With Retinopathy of Prematurity in Treated and Untreated Eyes: A Review of the Literature and Data From a Tertiary Eye-care Center in Southern India.治疗与未治疗眼的早产儿视网膜病变相关眼部疾病:来自印度南部一家三级眼科护理中心的文献及数据综述
Indian Pediatr. 2016 Nov 7;53 Suppl 2:S137-S142.
8
Retinopathy of prematurity: Past, present and future.早产儿视网膜病变:过去、现在与未来。
World J Clin Pediatr. 2016 Feb 8;5(1):35-46. doi: 10.5409/wjcp.v5.i1.35.
9
Outcomes for extremely premature infants.极早产儿的预后。
Anesth Analg. 2015 Jun;120(6):1337-51. doi: 10.1213/ANE.0000000000000705.
10
Recurrent vitreous hemorrhage associated with regressed retinopathy of prematurity in a 47-year-old patient: a case report.一名47岁患者复发性玻璃体出血与早产儿视网膜病变消退相关:病例报告
J Med Case Rep. 2014 Jun 10;8:183. doi: 10.1186/1752-1947-8-183.